174 related articles for article (PubMed ID: 28125080)
1. Genome editing in clinical genetics: points to consider-a statement of the American College of Medical Genetics and Genomics.
Acmg Board Of Directors
Genet Med; 2017 Jul; 19(7):723-724. PubMed ID: 28125080
[TBL] [Abstract][Full Text] [Related]
2. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics.
Acmg Board Of Directors
Genet Med; 2017 Jul; 19(7):721-722. PubMed ID: 28055021
[TBL] [Abstract][Full Text] [Related]
3. Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2015 Sep; 17(9):e3. PubMed ID: 26204421
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics.
ACMG Board of Directors
Genet Med; 2015 Jun; 17(6):505-7. PubMed ID: 25764213
[TBL] [Abstract][Full Text] [Related]
5. Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics.
ACMG Board of Directors
Genet Med; 2016 Feb; 18(2):207-8. PubMed ID: 26681314
[TBL] [Abstract][Full Text] [Related]
6. Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics.
Genet Med; 2018 Jun; 20(6):561. PubMed ID: 29388944
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
8. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation.
Shaffer LG;
Genet Med; 2005; 7(9):650-4. PubMed ID: 16301868
[TBL] [Abstract][Full Text] [Related]
9. Carrier screening in individuals of Ashkenazi Jewish descent.
Gross SJ; Pletcher BA; Monaghan KG;
Genet Med; 2008 Jan; 10(1):54-6. PubMed ID: 18197057
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS
Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454
[TBL] [Abstract][Full Text] [Related]
11. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
ACMG Board of Directors
Genet Med; 2015 Jan; 17(1):68-9. PubMed ID: 25356965
[TBL] [Abstract][Full Text] [Related]
12. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Stewart DR; Korf BR; Nathanson KL; Stevenson DA; Yohay K
Genet Med; 2018 Jul; 20(7):671-682. PubMed ID: 30006586
[TBL] [Abstract][Full Text] [Related]
13. Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Beck AE; Biesecker LG; Evans JP; Hamosh A; Holm IA; Martin CL; Richards CS; Rehm HL
Genet Med; 2018 Feb; 20(2):169-171. PubMed ID: 29323668
[TBL] [Abstract][Full Text] [Related]
14. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.
Mikhail FM; Heerema NA; Rao KW; Burnside RD; Cherry AM; Cooley LD
Genet Med; 2016 Jun; 18(6):635-42. PubMed ID: 27124785
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.
Sharer JD; Bodamer O; Longo N; Tortorelli S; Wamelink MM; Young S
Genet Med; 2017 Feb; 19(2):256-263. PubMed ID: 28055022
[TBL] [Abstract][Full Text] [Related]
16. Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.
Cooley LD; Morton CC; Sanger WG; Saxe DF; Mikhail FM
Genet Med; 2016 Jun; 18(6):643-8. PubMed ID: 27124786
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.
Strovel ET; Cowan TM; Scott AI; Wolf B
Genet Med; 2017 Oct; 19(10):. PubMed ID: 28682309
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).
Pasquali M; Yu C; Coffee B
Genet Med; 2018 Jan; 20(1):3-11. PubMed ID: 29261178
[TBL] [Abstract][Full Text] [Related]
19. Fragile X syndrome: diagnostic and carrier testing.
Sherman S; Pletcher BA; Driscoll DA
Genet Med; 2005 Oct; 7(8):584-7. PubMed ID: 16247297
[TBL] [Abstract][Full Text] [Related]
20. Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population.
Monaghan KG; Feldman GL; Palomaki GE; Spector EB; ;
Genet Med; 2008 Jan; 10(1):57-72. PubMed ID: 18197058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
